摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

NSC 661755 | 143168-23-4

中文名称
——
中文别名
——
英文名称
NSC 661755
英文别名
michellamine A3;michellamine A;michellamine B;michellamine C;5,5'-(1,1'-dihydroxy-8,8'-dimethoxy-6,6'-dimethyl[2,2'-binaphthalene]-4,4'-diyl)bis[1,2,3,4,-tetrahydro-1,3-dimethyl-6,8-isoquinolinediol];Michellamin B;(1R,3R)-5-[3-[4-[(1R,3R)-6,8-dihydroxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-5-yl]-1-hydroxy-8-methoxy-6-methylnaphthalen-2-yl]-4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl]-1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline-6,8-diol
NSC 661755化学式
CAS
143168-23-4
化学式
C46H48N2O8
mdl
——
分子量
756.896
InChiKey
GMLBVLXDRNJFGR-MOUTVQLLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    909.4±65.0 °C(Predicted)
  • 密度:
    1.282±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    8.3
  • 重原子数:
    56
  • 可旋转键数:
    5
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    164
  • 氢给体数:
    8
  • 氢受体数:
    10

SDS

SDS:f947b809191c07e900c24bd1a482ea1b
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    (R,R)-N-<1-(3,5-dimethoxyphenyl)-2-propyl>-α-methylbenzenemethanamine 在 palladium on activated charcoal 、 四(三苯基膦)钯 盐酸氢气三溴化硼碳酸氢钠caesium carbonate 、 silver sulfate 、 三乙胺silver(l) oxide三氯氧磷 作用下, 以 甲醇乙醇二氯甲烷N,N-二甲基甲酰胺甲苯 为溶剂, -78.0~110.0 ℃ 、101.33 kPa 条件下, 反应 80.5h, 生成 NSC 661755
    参考文献:
    名称:
    Total Synthesis of Michellamines A−C, Korupensamines A−D, and Ancistrobrevine B
    摘要:
    Efficient syntheses of the title compounds have been developed. Several strategies for preparation of each of the naphthalene and tetrahydroisoquinoline (THIQ) portions were developed. Initial attempts to use benzyne plus furan cycloaddition reactions were thwarted by the unfavorable sense of the regiochemical outcome. An interesting annulation reaction of benzynes derived from 2,4-dibromophenol derivatives formed the core of the shortest naphthalene synthesis. An alternative annulation initiated by the addition of a benzylic sulfone anion to methyl crotonate led to an efficient naphthol synthesis amenable to large scale. The THIQ synthesis of Bringmann was used initially and subsequently complemented by a route whose key step involved the opening of N-tosyl-2-methylethyleneimine by a 3,5-dimethoxyphenylcuprate reagent. The results from a variety of aryl cross-coupling reactions are described. Suzuki coupling of the boronic acid derived from the naphthalene moiety with a THIQ-iodide was the most generally effective method for forming the hindered biaryl bond. The korupensamines and ancistrobrevine B were then revealed by deprotection. The oxidative coupling of several 4-aryl-1-naphthols to indigoids (cross ring naphthoquinones) with silver oxide effected the critical dimerization reaction needed to establish the michellamine skeleton. For the perbenzylated precursor, hydrogen over palladium on carbon both reductively bleached the indigoid and hydrogenolyzed the benzyl ethers and amines to release the free michellamines. The synthesis of several michellamine analogues, including ent-michellamines, is outlined. Results of anti-HIV assays are presented.
    DOI:
    10.1021/jo9908187
点击查看最新优质反应信息

文献信息

  • BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
    申请人:Arvinas Operations, Inc.
    公开号:US20190300521A1
    公开(公告)日:2019-10-03
    The present disclosure relates to bifunctional compounds, which find utility as modulators of SMARCA2 or BRM (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a ligand that binds to the Von Hippel-Lindau E3 ubiquitin ligase, and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.
    本公开涉及双功能化合物,其作为SMARCA2或BRM(靶蛋白)的调节剂具有实用性。具体而言,本公开涉及包含一端结合Von Hippel-Lindau E3泛素连接酶的配体,另一端结合靶蛋白的双功能化合物,使得靶蛋白与泛素连接酶靠近以实现靶蛋白的降解(和抑制)。本公开展示了与靶蛋白降解/抑制相关的广泛药理活性。本公开的化合物和组合物用于治疗或预防由靶蛋白聚集或积累导致的疾病或紊乱。
  • COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 POLYPEPTIDES
    申请人:Arvinas, Inc.
    公开号:US20190151295A1
    公开(公告)日:2019-05-23
    The present disclosure relates to bifunctional compounds, which find utility as modulators of Interleukin-1 Receptor-Associated Kinase 4 (IRAK-4); the target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hppel-Lindau, cereblon, ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.
    本公开涉及双功能化合物,其作为白细胞介素-1受体相关激酶4(IRAK-4;目标蛋白)的调节剂具有实用性。具体而言,本公开涉及包含一端结合E3泛素连接酶的Von Hppel-Lindau、cereblon配体的双功能化合物,另一端结合目标蛋白的部分,使得目标蛋白靠近泛素连接酶以实现目标蛋白的降解(和抑制)。本公开展示了与目标蛋白的降解/抑制相关的广泛药理活性。本公开的化合物和组合物用于治疗或预防由目标蛋白聚集或积累导致的疾病或紊乱。
  • [EN] AMINE-LINKED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION<br/>[FR] DÉGRONIMÈRES DE C3-GLUTARIMIDE LIÉS À UNE AMINE POUR LA DÉGRADATION DE PROTÉINES CIBLES
    申请人:C4 THERAPEUTICS INC
    公开号:WO2017197051A1
    公开(公告)日:2017-11-16
    This invention provides amine-linked C3-glutarimide Degronimers and Degrons for therapeutic applications as described further herein, and methods of use and compositions thereof as well as methods for their preparation.
    这项发明提供了胺连接的C3-戊二酰亚胺Degronimers和Degrons,用于治疗应用,如本文进一步描述的,以及它们的使用方法、组合物以及它们的制备方法。
  • Efficient Syntheses of Korupensamines A, B and Michellamine B by Asymmetric Suzuki-Miyaura Coupling Reactions
    作者:Guangqing Xu、Wenzhen Fu、Guodu Liu、Chris H. Senanayake、Wenjun Tang
    DOI:10.1021/ja409669r
    日期:2014.1.15
    Efficient asymmetric Suzuki-Miyaura coupling reactions are employed for the first time in total syntheses of chiral biaryl natural products korupensamine A and B in combination with an effective diastereoselective hydrogenation, allowing ultimately a concise and stereoselective synthesis of michellamine B. Chiral monophosphorus ligands L1-3 are effective for the syntheses of a series of functionalized
    高效的不对称 Suzuki-Miyaura 偶联反应首次用于手性联芳基天然产物 korupensamine A 和 B 的全合成,并结合有效的非对映选择性氢化,最终实现了米歇尔胺 B 的简洁立体选择性合成。 手性单磷配体 L1-3通过不对称 Suzuki-Miyaura 偶联反应以优异的产率和对映选择性(高达 99% ee)合成一系列官能化手性联芳基化合物是有效的。高度极化的 BOP 基团与芳基硼酸偶联物的扩展 π 系统之间存在极性-π 相互作用被认为对于高对映选择性很重要。
  • [EN] C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION<br/>[FR] DÉGRONIMÈRES DE TYPE GLUTARIMIDE LIÉS AU CARBONE C3 POUR LA DÉGRADATION DE PROTÉINES CIBLES
    申请人:C4 THERAPEUTICS INC
    公开号:WO2017197046A1
    公开(公告)日:2017-11-16
    This invention provides Degronimers that have carbon-linked E3 Ubiquitin Ligase targeting moieties (Degrons), which can be linked to a targeting ligand for a protein that has been selected for in vivo degradation, and methods of use and compositions thereof as well as methods for their preparation.
    这项发明提供了一种Degronimers,它具有碳连接的E3泛素连接酶靶向基团(Degrons),可以与一个靶向配体相连,该配体针对的是在体内被选为降解的蛋白质,以及它们的使用方法和组成,以及它们的制备方法。
查看更多